|
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update
10/06/2025
|
|
|
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
09/03/2025
|
|
|
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
08/06/2025
|
|
|
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time
07/16/2025
|
|
|
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
06/04/2025
|
|
|
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement
05/21/2025
|
|
|
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement
05/15/2025
|
|
|
Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement
05/15/2025
|
|
|
Senseonics Holdings, Inc. Reports First Quarter Financial Results
05/08/2025
|
|
|
Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time
04/29/2025
|
|